OncoCyte competitors

OncoCyte Competitors include Thriva, hVIVO, Immucor and Ignyta.
Add company...
OncoCyte
OncoCyte
OncoCyte is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.
Thriva
Thriva
Thriva connects people with their body through finger prick blood tests.
hVIVO
hVIVO
hVIVO plc is the name of our LSE AIM-listed business, which was re-named and re-branded from Retroscreen Virology Group plc.
Immucor
Immucor
A global leader in transfusion and transplantation diagnostics.
Ignyta
Ignyta
Blazing a new future for cancer patients.
Founding Date
Founding Date
N/A
Founding Date
2015
Founding Date
1998
Founding Date
1982
Founding Date
2011
Type
Type
Public
Type
Private
Type
Public
Type
Private
Type
Subsidiary
Tags
Locations
Locations
Alameda, US HQ
Locations
Greater London, GB HQ
Locations
London, GB HQ
Locations
Norcross, US HQ
Locations
San Diego, US HQ
Employees
Employees
167% increase
Employees
2613% increase
Employees
25519% decrease
Employees
9581% decrease
Employees
N/A
Valuation ($)
Valuation ($)
61 m
Valuation ($)
N/A
Valuation ($)
57.1 m
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
2.5 k
Twitter followers
422
Twitter followers
160
Twitter followers
674

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
£11.9m (FY, 2017)
Revenue (est.)
$380m (FY, 2016)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
£8.1m (FY, 2017)
Cost of goods
$144m (FY, 2016)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
£3.8m (FY, 2017)
Gross profit
$236m (FY, 2016)
Gross profit
N/A
Net income
Net income
($19.4m) (FY, 2017)
Net income
N/A
Net income
(£9.5m) (FY, 2017)
Net income
($43.8m) (FY, 2016)
Net income
($103.6m) (FY, 2016)
For sources of this data, please see the company profileDownload Excel

View company profiles

Thriva
HQ
Greater London, GB
Employees
26↑ 13% increase

Thriva connects people with their body through finger prick blood tests.

View company
hVIVO
HQ
London, GB
Employees
255↓ 19% decrease

hVIVO plc is the name of our LSE AIM-listed business, which was re-named and re-branded from Retroscreen Virology Group plc.

View company
Immucor
HQ
Norcross, US
Employees
958↓ 1% decrease

A global leader in transfusion and transplantation diagnostics.

View company
Ignyta
HQ
San Diego, US

Blazing a new future for cancer patients.

View company